In vitro activity of imipenem/relebactam against non-Morganellaceae Enterobacterales and Pseudomonas aeruginosa in Latin America: SMART 2018¿2020 James A. Karlowsky; Sibylle H. Lob; Fakhar Siddiqui; Jacqueline Pavia; C. Andrew DeRyke; Katherine Young; Mary R. Motyl; Daniel F. Sahm;

In vitro activity of ceftazidime-avibactam against Enterobacterales and Pseudomonas aeruginosa isolates collected in Latin America as part of the ATLAS global surveillance program, 2017¿2019 James A. Karlowsky; Krystyna M. Kazmierczak; Maria Lavínea Novis de Figueiredo Valente; Elkin Lemos Luengas; Monique Baudrit; Alvaro Quintana; Paurus Irani; Gregory G. Stone; Daniel F. Sahm;

Evaluation of in vitro activity of ceftolozane¿tazobactam against recent clinical bacterial isolates from Brazil ¿ the EM200 study Felipe Francisco Tuon; Juliette Cieslinski; Suellen da Silva Rodrigues; Fernando Brandão Serra; Marina Della-Negra de Paula;